Policy & Regulation
Kaneka unveils the PCR Test Kit that detects four COVID-19 variants in single PCR test
11 October 2021 -

Japanese chemical company Kaneka Corporation (TOKYO:4118) reported on Sunday the availability of the KANEKA RT-PCR Kit SARS-CoV-2 real-time PCR test kit that is capable of simultaneously detecting four variants of COVID-19, with retail price of JPY217,800.

Effective 30 September 2021, the company's reagent simultaneously detects four mutations 1 of spike protein (the N501Y, E484K, E484 and L452R mutations) with a single PCR test. It can efficiently detect two variants (the Alpha, Delta, Kappa and Beta or Gamma variants).

In conjunction, the PCR kit for detecting COVID-19 has received approval in June 2021 as "KANEKA Direct RT-PCR kit SARS-CoV-2" for use as an In-Vitro Diagnostic reagent. It is widely used in medical facilities and testing centres. By adding this new COVID-19 variant PCR test kit to its lineup, the company is contributing to the rapid detection of variants and the prevention of the spread of COVID-19.

To combat COVID-19, the company conducts research and development regarding infection control measures including COVID-19, performs contract manufacturing of DNA vaccine APIs and intermediates, supplies the API used in AviganTM, develops antibody drugs, supplies PCR testing reagents and testing kits as well as shipping vaccines using temperature controlled packages.